For the first time Astronomy and Pathology (AstroPath™) come together to discover and clinically validate new spatial phenotypic signatures using multiplex immunofluorescence
Funding will advance 3D lung cell culture models to accelerate drug discovery
Discovery is a result of Abbott's continued virus hunting efforts, which also uncovered a new strain of HIV in 2019
The partnership will pair Personalis’ NeXT tumor profiling with Natera’s Signatera™ for treatment monitoring
Explore hot topics from 3D X-ray microscopy and in vitro diagnostics to gas chromatography and synthetic guide RNAs
The update provides alternative temperature for transportation and temporary storage for frozen vials before dilution
The research brings a deeper understanding about how fructose could be linked to diabetes and obesity
International experts are joining forces to combat vaccine hesitancy by tackling its root cause
The Genedrive 96 SARS-CoV-2 kit is a simple, one-step RT-PCR test to detect SARS-CoV-2 RNA
Companion diagnostic can help guide treatment decisions in cases of NSCLC
Focusing on innate immunity opens way for precision medicine approaches to AD
Company expands portfolio of SARS-CoV-2 testing solutions with rapid antigen test benchmarked against gold standard RT-PCR
Explore topics from in vitro diagnostics and advances in COVID-19 sample prep to neonatal hypocalcemia and cytotoxicity assay development
Eight-marker panel, including new long mononucleotide repeat (LMR) markers, enables broader view of mismatch repair deficiency
RHB-107 is a novel serine protease inhibitor targeting human cell factors involved in viral entry, and is therefore expected to be effective against emerging viral variants with mutations in the spike protein
Discover the latest technologies and techniques to aid research into the biology, detection, and prevention of SARS-CoV-2 infection
Join us on Friday, February 26, to find out how to effectively profile the host response to COVID-19 infection using the next-generation automated ELISA, Ella
Explore topics from therapeutic antibodies and advances in COVID-19 sample prep to neonatal hypocalcemia and cytotoxicity assay development
The testing capacity provided by the Fluidigm system aims to help the university limit the spread of the virus
